Cell Therapy Products in Menopausal Medicine - Wikidata - awgldk - TriplyDB

Cell Therapy Products in Menopausal Medicine

Cell Therapy Products in Menopausal Medicine

http://www.wikidata.org/entity/Q28076744

about

The Relationship between Renal Function and Bone Marrow Density in Healthy Korean Women.

P2860

Q41689262-8BE9C3AD-40AA-4971-862C-0BBD1ED1D0DB

P2860

Cell Therapy Products in Menopausal Medicine

http://www.wikidata.org/entity/Q28076744

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Cell Therapy Products in Menopausal Medicine

@ast

Cell Therapy Products in Menopausal Medicine

@en

Cell Therapy Products in Menopausal Medicine

@nl

type

label

Cell Therapy Products in Menopausal Medicine

@ast

Cell Therapy Products in Menopausal Medicine

@en

Cell Therapy Products in Menopausal Medicine

@nl

prefLabel

Cell Therapy Products in Menopausal Medicine

@ast

Cell Therapy Products in Menopausal Medicine

@en

Cell Therapy Products in Menopausal Medicine

@nl

P1433

Q28076744-F904FD56-7E31-433A-891B-67EE9E15B40F

P1476

Q28076744-21FCB26D-5263-408F-855B-2FECD13C8BFB

P2093

Q28076744-1E61DDA2-E034-45E5-BEE9-C473EA936135

Q28076744-23143955-3732-4A36-A5F2-EB7CF1B2B455

Q28076744-35B7CEAA-BD07-453F-BED9-E0CDCF6F9E25

Q28076744-6BD8083D-CC6E-4A29-AD2E-1DC018AAEB90

Q28076744-AC8BD829-1AE0-497C-B456-0C9B37314941

Q28076744-BAA9CDBA-18E7-4AD6-97E5-F015805841E5

Q28076744-C227E487-ADC3-488D-BE8E-8752D4E16D09

P2860

Q28076744-09C451E4-5E3C-4D69-95F9-06BBD83C518D

Q28076744-473AE601-E2A4-4032-B367-C12C451143F1

Q28076744-6037188F-5A5B-40C1-8D6A-CB776C8890F9

Q28076744-69485A10-09F9-4286-8964-2BA671DB9A36

Q28076744-73B9FEF0-FE49-4411-B70F-9309F2B6DC6D

Q28076744-84C21325-AE0F-4589-B2DF-0106B4ACDA8B

Q28076744-90EAACD7-87E1-4587-8556-4FB0758AC6B8

Q28076744-ABF64583-8C93-4F7C-894B-B064BDA350AA

Q28076744-B6A8B6B5-3F0B-46A5-AE0B-A745E61EBD95

Q28076744-C69C35C8-1C23-4A86-BF8B-572A85C7168C

P304

Q28076744-D9841618-1A8D-4AB0-9242-B69388C1AB34

P31

Q28076744-28654A7C-D42A-41D3-B208-B5FF8B248166

P3181

Q28076744-EE4D886A-85DE-47DD-9A55-3AD842DE07BE

P356

Q28076744-57C01EE3-9B1E-4B08-B4A3-FB68EA67A288

P407

Q28076744-F738B2A7-42AE-464B-AE51-5D7074A6E254

P433

Q28076744-22639583-ECEF-4253-90FF-BFEB803B4931

P478

Q28076744-0DBA76D7-736C-4D02-A2D0-BDE54D7125B3

P577

Q28076744-41691E50-ECC6-4609-982C-426BA6ADA71F

P698

Q28076744-91C3C22D-AF14-4335-B21A-18AD7E62B663

P932

Q28076744-790583F3-18FC-442B-80BB-9198D6E2AB02

P3181

P356

JMM.2016.22.2.71

P1433

Journal of menopausal medicine

P1476

Cell Therapy Products in Menopausal Medicine

@en

P2093

Arum Lee

http://www.w3.org/2001/XMLSchema#string

Hye Ji Choi

http://www.w3.org/2001/XMLSchema#string

Hyeon Jin Song

http://www.w3.org/2001/XMLSchema#string

Jun-Mo Kim

http://www.w3.org/2001/XMLSchema#string

Soo Ah Kim

http://www.w3.org/2001/XMLSchema#string

Tae-Hee Kim

http://www.w3.org/2001/XMLSchema#string

Yoo Jin Park

http://www.w3.org/2001/XMLSchema#string

P2860

Endometriosis in a postmenopausal woman on hormonal replacement therapy.

The Relationship between Uterine Myoma Growth and the Endocrine Disruptor in Postmenopausal Women.

Menopause Knowledge, Attitude, Symptom and Management among Midlife Employed Women.

Is complementary and alternative therapy effective for women in the climacteric period?

Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes

Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice.

Mesenchymal Stem Cells and Their Clinical Applications in Osteoarthritis.

The osteoimmunology of alveolar bone loss.

Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.

A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma.

P304

71-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3817823

http://www.w3.org/2001/XMLSchema#string

P356

10.6118/JMM.2016.22.2.71

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27617240

http://www.w3.org/2001/XMLSchema#string

P932

5016506

http://www.w3.org/2001/XMLSchema#string